Cizzle Biotechnology Holdings Plc (LON:CIZ)

Market Cap	4.67M -15.8%
Revenue (ttm)	n/a
Net Income	-652.00K
EPS	-0.00
Shares Out	424.96M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,623,914
Open	1.150
Previous Close	1.400
Day's Range	0.900 - 1.300
52-Week Range	0.900 - 3.900
Beta	-0.09
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 29, 2026

About LON:CIZ

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood immunoassay test for early lung cancer detection using CIZ1B biomarker technology. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.

• Industry: Biotechnology
• Sector: Healthcare
• Employees: 5
• Stock Exchange: London Stock Exchange
• Ticker Symbol: CIZ

Financial Performance

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 15, 2026

Data Sources Report a data error